Setpoint, the operating system for asset-backed finance, today announced that it has signed an agreement to acquire inTENT Fulfillment, a specialized loan diligence and transaction management firm ...

Our team of savvy editors independently handpicks all recommendations. If you make a purchase through our links, we may earn a commission. Deals and coupons were accurate at the time of publication ...

[Image from the SetPoint Medical website] SetPoint Medical announced today that it received CMS payment status for its SetPoint neuroimmune modulation device. The Centers for Medicare & Medicaid ...

I have always been a fan of Logitech mice, I mean, who isn’t? But I’m not a fan of reading the words “Logitech International S.A. ("Logitech") recently experienced a cybersecurity incident relating to ...

Hardware accessory giant Logitech has confirmed it suffered a data breach in a cyberattack claimed by the Clop extortion gang, which conducted Oracle E-Business Suite data theft attacks in July.

SetPoint Medical to Present Data at ACR Convergence 2025 Demonstrating Sustained Efficacy and Safety for the SetPoint System to Treat Rheumatoid Arthritis Four presentations highlight 12-month ...

The G502 X isn't a whole lot different to the older G502 gaming mice, but manages to bring some useful ergonomic and weight tweaks to an already stellar design, in order to make it appeal more to FPS ...

Mississauga, Ontario — Kingstec Technologies, a leader in project management, engineering, manufacturing, and logistics solutions, proudly celebrates the U.S. Food and Drug Administration’s approval ...

Northwell Health and SetPoint Medical today announced that Northwell is the first health system to provide the recent U.S. Food and Drug Administration (FDA)-approved SetPoint ® System to patients, ...

Fresh after getting the green light from the U.S. Food and Drug Administration, SetPoint Medical raises $140 million to market and distribute its rheumatoid arthritis treatment. SetPoint Medical Chief ...

SetPoint Medical, a Valencia-based company dedicated to developing therapies for people living with chronic autoimmune diseases, raised $140 million in private financing that includes $25 million in ...